Sonia Quaratino has become the first chief medical officer of Kymab Group Ltd, the UK antibody therapeutics developer. She joins from Novartis where she was responsible for that company’s antibody-based immuno-oncology programmes. Prior to this she was senior medical director and immunology advisor at Merck Serono (Merck KGaA).
Dr Quaratino holds a PhD in immunology from Imperial College London as well as a medical degree and doctorate in haematology-oncology from the University of Palermo in Italy.
Kymab announced the appointment on 9 May 2017.
Copyright 2017 Evernow Publishing Ltd